Asieris Pharma's Series B Round

Asieris Pharma raised a round of funding on December 27, 2017.

Asieris Pharma (亚虹医药) is a Chinese company focused on cancer. The company is developing a repurposed oral inhibitor of MetAP2, a spectrum antibiotic that has been shown to have an anti-angioge…

Articles about Asieris Pharma's Series B Round: